Current Drug Targets

Editor-in-Chief:

Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

Back

Become EABM
Become Reviewer

Preface [Hot Topic:Inflammatory Markers and Mediators: Emerging Therapeutic Targets in Diabetes, Cardiovascular and Metabolic Disorders (Guest Editor: Samuel Dagogo-Jack, MD)]. promotion: free to download

Volume:4   Issue:6
Pp: iii-iii
Samuel Dagogo-Jack
DOI: 10.2174/1389450110304060iii

Drug Resistance to Cytotoxic Nucleoside Analogues

Volume:4   Issue:6
Pp: 443-460
L. Jordheim, C. M. Galmarini and C. Dumontet
DOI: 10.2174/1389450033490957

Non-steroidal Anti-inflammatory Drugs and Cyclooxygenase in Alzheimer s Disease

Volume:4   Issue:6
Pp: 461-468
Jeroen J.M. Hoozemans, Robert Veerhuis, Annemieke J.M. Rozemuller and Piet Eikelenboom
DOI: 10.2174/1389450033490902

Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions

Volume:4   Issue:6
Pp: 487-492
Rajesh Garg, Devjit Tripathy and Paresh Dandona
DOI: 10.2174/1389450033490920

Activated T Lymphocytes in Type 2 Diabetes: Implications From in Vitro Studies

Volume:4   Issue:6
Pp: 493-503
Frankie B. Stentz and Abbas E. Kitabchi
DOI: 10.2174/1389450033490966

Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets

Volume:4   Issue:6
Pp: 505-516
Karl T. Weber, Ivan C. Gerling, Mohammad F. Kiani, Ramareddy V. Guntaka, Yao Sun, Robert A. Ahokas, Arnold E. Postlethwaite and Kenneth J. Warrington
DOI: 10.2174/1389450033490948